Tag Archives: science
PARP Inhibitor Olarparib Fails to Meet Trial Endpoints
EU Approves Use of Avastin for Ovarian Cancer
Bilateral Oophorectomy Associated With Higher Prevalence of Low Bone Mineral Density and Arthritis in Younger Women
A study presented at a breast cancer conference showed a link between lower bone density and removal of the ovaries. Women who had both ovaries removed before 45 years of age and who never used HRT had a lower BMD … Continue reading
Posted in News
Also tagged outcomes, prevention, quality of life, recurrence, side effects
Leave a comment
Mutation in KRAS Gene May Indicate Drug Resistance in Ovarian Cancer Patients
A genetic mutation that causes a change in the KRAS pathway appears to be linked to higher likelihood of platinum resistance in women with ovarian cancer. The KRAS pathway is active in other types of tumors, including colorectal. Read the … Continue reading
Posted in News
Also tagged chemotherapy, genetics, outcomes, recurrence, Research, resistance, treatment
Leave a comment
Screening Study for Ovarian Cancer
A new study of 545 women with a family history of ovarian cancer were provided annual screening with the CA-125 blood test and transvaginal ultrasound. This interval of testing with these tools did not find any early stage ovarian cancers. Read … Continue reading
HE4 May be Helpful in Screening
Fat Cells in the Omentum Help Fuel Ovarian Cancer
IVF Raises Risk of Ovarian Cancer
A study of 25,000 women, 19,000 of whom received In-Vitro Fertilization (IVF) found that the women who underwent IVF had higher rates of ovarian cancer. The cases of ovarian cancer in women who had IVF were borderline tumors. The women … Continue reading
The Pill Halves the Risk of Ovarian Cancer
A new study of more than 300,000 women, 878 of whom developed ovarian cancer over an almost 10 year period, showed that women who took oral contraceptives (The Pill) had almost half the rate of ovarian cancer as those who … Continue reading
Women with BRCA2 Mutation in Ovarian Tumors have Higher Surivival Rates
A recent study shows that women with ovarian cancer who have the BRCA2 mutation live longer than those with the BRCA1 mutation. Because the BRCA1 and BRCA2 mutations works slightly differently, they have a different effect on survival. The BRCA2 … Continue reading
Posted in News
Also tagged cancer treatment, chemotherapy, clinical trials, genetics, outcomes, Research, treatment
Leave a comment
Ovarian Cancer a Mystery, Especially for Black Women
The Grio reports that African American women are not well represented in clincial trials related to ovarian cancer. The article discusses a new trial meant to explore the epidemiology of ovarian cancer in African American women. Read the full article … Continue reading
Posted in News
Also tagged clinical trials, genetics, outcomes, Research, risk, women's health
Leave a comment
Carbo/Paclitaxel v. Carbo/PLD as first line treatment for Ovarian Cancer
A recently study evaluated standard first line therapy – carboplatin plus paclitaxel – against carboplatin plus Doxil (PLD). This study of more than 800 women found that the use of Doxil was not superior to standard therapy, although the women … Continue reading
